In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hexal AG

Division of Novartis AG
www.hexal.de

Latest From Hexal AG

Sandoz' Hexal Wins Landmark German Case Over Desloratadine Switch

Sandoz, through its Hexal subsidiary, has won an important case against the German Ministry of Health over a delayed prescription-to-OTC switch of desloratadine, which shows European Union Member States have got the authority to switch at a national level centrally authorized drugs.

Legal Issues OTC Drugs

Ranitidine Recalls Begin As European Regulators Take Action

OTC ranitidine products are among the first to be recalled in Europe following the discovery of a human carcinogen in ranitidine-based drugs.With investigations underway worldwide, regulators across Europe are split into two camps: immediate action or wait and see.

Product Recalls Drug Safety

Generics Players Dominating New OTC Launches In Germany

An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.
Health OTC Drugs

Generics Players Dominating New OTC Launches In Germany

An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.
Health OTC Drugs
See All

Company Information

UsernamePublicRestriction

Register